<?xml version="1.0" encoding="UTF-8"?>
<p id="Par57">This is when Indonesia made its move. In December 2006, Indonesian Health Minister, Dr. Siti Fadilah Supari announced that Indonesia was withdrawing its support from the GISN. It would no longer be sharing its virus samples until it could be guaranteed fairer access to the vaccines and antivirals created using them.
 <xref ref-type="fn" rid="Fn39">39</xref> The Indonesians cited the CBD as the basis for their argument, claiming sovereign control over the influenza viruses isolated within their territory.
 <xref ref-type="fn" rid="Fn40">40</xref> Since ratifying the CBD in the mid-1990s, Indonesian domestic law required that international transfers of biological materials occurred under material transfer agreements (MTAs), but Indonesia had apparently “made a dispensation and had faithfully shared the specimens to the WHO system”.
 <xref ref-type="fn" rid="Fn41">41</xref> Indonesia highlighted what it saw as the unfair practices of the GISN: expecting individual nations to freely provide the raw materials required by pharmaceutical companies to produce vaccines and antivirals, that were then patented and sold at a profit to those provider nations.
 <xref ref-type="fn" rid="Fn42">42</xref>
</p>
